Financial Performance - Net sales for Q2 2024 reached 6,112million,aslightincreasefrom6,045 million in Q2 2023, representing a growth of 1.1%[1] - Net income attributable to Corteva for Q2 2024 was 1,053million,comparedto714 million in Q2 2023, marking a significant increase of 47.4%[1] - Basic earnings per share from continuing operations for Q2 2024 was 1.51,upfrom1.23 in Q2 2023, an increase of 22.8%[1] - Net income for the six months ended June 30, 2024, was 1,479million,comparedto1,316 million in the same period of 2023, representing a 12.4% increase[5] - Operating EBITDA for the second quarter of 2024 was 1,917million,anincreasefrom1,746 million in 2023, reflecting a growth of 9.8%[11] - Operating earnings (Non-GAAP) for the second quarter of 2024 were 1,905million,comparedto1,972 million in 2023[30] - Operating Earnings (Non-GAAP) for Q2 2024 reached 1,280million,comparedto1,139 million in Q2 2023, an increase of 12.4%[33] - Operating Earnings Per Share (Non-GAAP) for Q2 2024 was 1.83,upfrom1.60 in Q2 2023, reflecting a growth of 14.4%[33] Sales and Revenue Breakdown - Total net sales for the second quarter of 2024 were 6,112million,withorganicsalesincreasingto6,172 million, reflecting a growth of 1% from the previous year[10] - Seed segment net sales for the first half of 2024 reached 7,082million,upfrom6,959 million in 2023, indicating a 1.8% increase[6] - Crop protection segment net sales for the first half of 2024 were 3,522million,downfrom3,970 million in 2023, showing a decrease of 11.3%[7] - North America net sales increased by 81million,a283 million, also a 2% increase[13] - EMEA region experienced a decline in net sales of 41million,a67 million, a 1% increase[13] - Latin America saw a net sales increase of 42million,a741 million, a 7% increase[13] - Asia Pacific reported a net sales decline of 15million,a4(4) million, a decrease of 1%[13] - Total net sales for Corteva, Inc. increased by 67million,a1127 million, a 2% increase[13] Expenses and Costs - The cost of goods sold decreased to 2,918millioninQ22024from3,137 million in Q2 2023, a reduction of 7.0%[1] - Research and development expenses increased to 357millioninQ22024,upfrom329 million in Q2 2023, reflecting an increase of 8.5%[1] - The company reported capital expenditures of (262)millionforthefirsthalfof2024,slightlyhigherthan(250) million in the same period of 2023[5] - The company recognized significant restructuring and asset-related charges of (92)millioninthesecondquarterof2024,comparedto(60) million in the same quarter of 2023[23] Assets and Liabilities - Total assets as of June 30, 2024, were 41,464million,downfrom42,996 million at the end of 2023, a decrease of 3.6%[2] - Cash and cash equivalents decreased to 1,839millionasofJune30,2024,from2,644 million at the end of 2023, a decline of 30.4%[2] - Total current liabilities decreased to 8,953millionasofJune30,2024,from10,409 million at the end of 2023, a reduction of 13.9%[3] - Total stockholders' equity increased to 25,421millionasofJune30,2024,comparedto25,279 million at the end of 2023, an increase of 0.6%[4] Cash Flow and Financing - Cash provided by operating activities for continuing operations was (1,999)millionforthefirsthalfof2024,comparedto(2,480) million in 2023, an improvement of 19.4%[5] - The net change in borrowings for the first half of 2024 was 628million,comparedto885 million in the same period of 2023[5] - Cash, cash equivalents, and restricted cash equivalents at the end of the period were 2,141million,downfrom2,963 million at the end of the previous year[5] - Free Cash Flow for the first half of 2024 is projected to be between 1,500millionand2,000 million, with capital expenditures estimated at 630million[40]TaxandExchangeLosses−Thebaseincometaxratefromcontinuingoperations(Non−GAAP)forQ22024was22.548 million for Q2 2024, compared to a loss of 91millioninQ22023[37]−Incomefromcontinuingoperationsbeforeincometaxes(GAAP)forQ22024was1,338 million, up from 1,084millioninQ22023,indicatingagrowthof23.578 million in Q2 2024, down from a loss of $104 million in Q2 2023[37]